Molnupiravir represents a important development in the ongoing fight against SARS-CoV-2. This oral agent works by introducing errors into the virus's replication machinery, effectively halting its ability to spread. While preliminary clinical research showed promising results in reducing the likelihood of hospitalization and death in high-risk peop

Linaclotide, often prescribed for chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C), represents a unique approach to gastrointestinal health. This GC-C agonist works directly within the intestines to increase fluid secretion and accelerate bowel movements. Unlike traditional laxatives that primarily act on the c